Using an improvement model to reduce adverse drug events in VA facilities.
暂无分享,去创建一个
P B Batalden | R S Dittus | P. Mills | R. Dittus | D. Aron | W. Weeks | P. Batalden | W B Weeks | P D Mills | D C Aron
[1] N. Laird,et al. Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention , 1995 .
[2] L. Baker,et al. Managed care and technology diffusion: the case of MRI. , 1998, Health affairs.
[3] H Pohl,et al. Medication prescribing errors in a teaching hospital. , 1990, JAMA.
[4] D. Bates,et al. The Costs of Adverse Drug Events in Hospitalized Patients , 1997 .
[5] D. Bates,et al. Systems analysis of adverse drug events. ADE Prevention Study Group. , 1995, JAMA.
[6] S. Crystal,et al. The diffusion of innovation in AIDS treatment: zidovudine use in two New Jersey cohorts. , 1995, Health services research.
[7] J. Coleman,et al. Medical Innovation: A Diffusion Study. , 1967 .
[8] T W Nolan,et al. Reducing adverse drug events: lessons from a breakthrough series collaborative. , 2000, The Joint Commission journal on quality improvement.
[9] E. Steinberg,et al. X-ray CT and magnetic resonance imagers. Diffusion patterns and policy issues. , 1985, The New England journal of medicine.
[10] L. Dintenfass. HONESTY IN CONFUSION. , 1965, Lancet.
[11] L. Kohn,et al. To Err Is Human : Building a Safer Health System , 2007 .
[12] A. Kasumi,et al. The Spread of Upper Gastrointestinal Endoscopy in Japan and the United States: An International Comparative Analysis of Technology Diffusion , 1993, International Journal of Technology Assessment in Health Care.
[13] R. Busse,et al. CARDIAC CATHETERIZATION IN GERMANY , 1999, International Journal of Technology Assessment in Health Care.
[14] J C Russo,et al. Medication error prevention by clinical pharmacists in two children's hospitals. , 1987, Pediatrics.
[15] D. Menon,et al. Diffusion of Laparoscopic Cholecystectomy in Canada , 1994, International Journal of Technology Assessment in Health Care.
[16] Lucian L. Leape,et al. Reducing adverse drug events , 1998 .
[17] M. Nichter,et al. Changing patterns of pharmaceutical practice in the United States. , 1997, Social science & medicine.
[18] D. Classen,et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. , 1997, JAMA.
[19] R. Shepherd,et al. The challenge of disseminating new medical technologies: treatment of cardiac arrhythmias. , 1990, QRB. Quality review bulletin.
[20] TonseN. K. Raju,et al. MEDICATION ERRORS IN NEONATAL AND PAEDIATRIC INTENSIVE-CARE UNITS , 1989, The Lancet.
[21] A. D. Spiegel,et al. Risk Management in Health Care Institutions: A Strategic Approach , 1997 .
[22] Schwartz Js,et al. The adoption and diffusion of CT and MRI in the United States. A comparative analysis. , 1985 .
[23] J A Shea,et al. Diffusion of Laparoscopic Cholecystectomy Among General Surgeons in the United States , 1995, Medical care.
[24] T. Brennan,et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. , 1991, The New England journal of medicine.
[25] D S Stein,et al. Factors related to errors in medication prescribing. , 1997, JAMA.
[26] K. Levit,et al. Health spending in 1998: signals of change. The Health Accounts Team. , 2018, Health affairs.
[27] W. W. Young,et al. Dissemination of clinical results. Mastectomy versus lumpectomy and radiation therapy. , 1996, Medical care.
[28] B. Kirkman-Liff,et al. The hepatitis B vaccine: utilization decision process and outcomes in community hospitals. , 1985, Health services research.
[29] A. Fendrick,et al. Hospital adoption of laparoscopic cholecystectomy. , 1994, Medical care.
[30] James T. Reason,et al. Managing the risks of organizational accidents , 1997 .
[31] E. G. Elinsky,et al. Magnetic Resonance Imaging: Diffusion of Technology in an Ambulatory Setting , 1992, International Journal of Technology Assessment in Health Care.
[32] M. Pollard. Pharmaceutical Innovation in the United States: Factors Affecting Future Performance , 1993, International Journal of Technology Assessment in Health Care.